Investing in marijuana stocks in 2017 was largely defined by a massive surge in Canadian companies as they prepared for federal recreational legalization. While U.S.-based stocks and cannabinoid biotechs saw mixed results, several Canadian growers delivered triple-digit returns.
: Despite state-level progress, U.S. federal prohibition remained a significant risk for domestic companies. best marijuana stocks to buy 2017
: Stocks like GW Pharmaceuticals (GWPH) remained popular for their work on cannabinoid-derived drugs like Epidiolex for epilepsy. Investing in marijuana stocks in 2017 was largely
: The Canadian market far outpaced the U.S. due to clearer paths toward full legalization. federal prohibition remained a significant risk for domestic
: Companies like Scotts Miracle-Gro (SMG) gained attention for providing hydroponics and fertilizer equipment to growers, offering a "pick and shovel" approach to the industry.
The following companies were the primary winners of the year, driven by expansion into international markets and major corporate partnerships.
: This Canadian medical grower saw its stock more than quadruple (up over 300%). Key Investment Themes in 2017